Clinical Trial Update: BMS-247550 in Treating Patients With Liver or Gallbladder Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study of BMS-247550 in adult cholangiocarcinoma, hepatocellular carcinoma, and gallbladder cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Gallbladder Cancer
• Hepatocellular Carcinoma

Drugs mentioned

• BMS-247550

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Primary Cholangiocellular Carcinoma, Adult Primary Hepatocellular Carcinoma | Phase 2 | Status: TERMINATED